Alnylam Pharmaceuticals Inc ALNY Phase 2 Diabetes Drug Progress and SP 500 Contender Status Lift Bullish Outlook Salesforce Inc CRM Bearish Risks Mount Amid AI Pricing Pushback Competitive Pressures and Federal Contract Uncertainty Two TWOC Stock Risk vs Reward Analysis